NADH vs NMN: Human Trials Tested 20–40 mg vs 300–900 mg
For short-term energy and fatigue, NADH tends to work faster; for building and holding your NAD+ pool over time, NMN is the stronger long-term pick. Human trials show NMN raises blood NAD levels in a dose-dependent way, while smaller NADH trials point to endurance and fatigue benefits. The right choice depends on whether your goal is immediate output or sustained cellular health.
TL;DR:
- NMN trials used 300 to 900 milligrams daily and raised blood NAD by days 30 and 60, though blood levels may not reflect tissue levels.
- After three weeks, a trial of sublingual NADH at 40 milligrams daily reported 25.6% higher PWC170 scores and 23.9% higher estimated VO2max.
- Safety over extended use remains uncertain for both supplements; pregnant or breastfeeding people, anyone taking prescriptions, or seriously ill people should consult a clinician.
- Check that a product lists a dose used in human trials and discloses independent testing, since manufacturing quality varies between supplements.
Table of Contents
- Quick comparison: roles, use cases and evidence at a glance
- What NAD+, NMN and NADH are
- How supplements reach cells and the key pharmacokinetic debates
- Human trials: what they tested, what they found, and what to watch for
- Which to choose for your goal and how to evaluate products
- Dose ranges seen in trials and common product forms
- Safety signals, common side effects and when to seek medical advice
- Author and publisher proof points: Jord and Vivetus
- How to choose between NADH and NMN
- Finding the right NMN product for your routine
- FAQ
- Sources
Quick comparison: roles, use cases and evidence at a glance
NMN and NADH feed the same system from different directions, and that difference shapes what each one is good for.
- NMN: a direct precursor to NAD+, better suited to long-term NAD maintenance and healthy ageing strategies.
- NADH: a reduced cofactor already active in mitochondrial energy production, better suited to short-term fatigue or endurance support.
- Evidence strength: NMN has larger, dose-dependent trials measuring blood NAD; NADH trials are smaller but show functional endurance gains.
- Typical doses: NMN trials commonly used 300 to 900 milligrams per day; NADH trials often used 20 to 40 milligrams per day, frequently sublingual.
- Onset: NADH effects on endurance have appeared within three weeks; NMN’s blood NAD changes have been measured at 30 and 60 days.
What NAD+, NMN and NADH are
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme every cell needs to convert food into usable energy and to support DNA repair. NADH is simply the reduced, electron-carrying form of that same molecule: it hands off electrons inside the mitochondria during ATP production, then becomes NAD+ again. The balance between the two, known as the NAD+/NADH ratio, reflects how efficiently your cells are generating energy.
NMN (nicotinamide mononucleotide) is not NAD+ itself but a building block your body converts into it. Once formed, NAD+ fuels enzymes called sirtuins and PARPs, which support cellular repair, gene regulation and metabolic signalling. In simple terms: NMN feeds into NAD+, NAD+ gets used by repair enzymes, and NADH shuttles electrons during the energy-making step itself.
How supplements reach cells and the key pharmacokinetic debates
Oral NMN is widely assumed to enter cells directly, but a notable mechanistic detail complicates that picture: NMN is often dephosphorylated outside cells into NR before uptake, meaning the molecule that started as NMN may not arrive inside cells in its original form. A review of NAD+ precursor pharmacokinetics notes that different precursor routes, including NAM, NR and NMN, behave differently, and that reduced forms may raise NAD+ more strongly in some animal models, though human translation remains uncertain.
NADH, by contrast, is a larger and less stable molecule, which is why trials have tested sublingual delivery to bypass digestive breakdown. A further complication applies to both compounds: a rise in blood NAD does not automatically mean a matching rise inside tissues, since blood and cellular compartments do not always move together. This gap is one reason academic reviews call for more direct human comparisons.
Human trials: what they tested, what they found, and what to watch for
The clearest NMN data comes from a randomised, multicentre, dose-dependent trial in 80 healthy middle-aged adults, where doses of 300, 600 and 900 milligrams per day significantly raised blood NAD concentrations by day 30 and day 60, with no safety issues reported. A separate 60-day trial of Uthever NMN in 66 adults, using 300 milligrams per day, found serum NAD+/NADH rose by roughly 38% versus baseline, alongside modest improvements in walking endurance and SF-36 quality-of-life scores, though the authors called for larger trials.
NADH evidence is smaller in scale but still instructive. A randomised trial of sublingual NADH at 40 milligrams per day found PWC170 scores rose by 25.6% and estimated VO2max by 23.9% after three weeks, with no change in leukocyte NAD+/NADH markers. Separate trials combining NADH with coenzyme Q10 in people with chronic fatigue reported improved fatigue and quality-of-life scores over 8 to 12 weeks. Sample sizes stay small across both compounds, and manufacturing quality varies between products.
Which to choose for your goal and how to evaluate products
Matching the supplement to the goal keeps the decision simple: reach for NADH when you want support for fatigue or exercise endurance, and reach for NMN when the aim is maintaining your NAD+ pool for metabolic and ageing-related goals over months.
- Fatigue or endurance: NADH, generally in sublingual form, aligns with the trial doses that showed measurable gains.
- Long-term NAD maintenance: NMN, taken consistently, aligns with the dose-dependent trials showing sustained blood NAD increases.
- Check the label: confirm the product states a dose within trial-tested ranges and discloses third-party testing.
Pro Tip: Compare the milligram dose on the label against the doses actually used in trials, since a product sold at a fraction of the tested dose is unlikely to reproduce the trial’s results.
Dose ranges seen in trials and common product forms
NMN trials have used doses from 300 up to 900 milligrams per day, with the largest blood NAD increases seen at the higher end of that range. NADH trials have generally used smaller amounts per day, almost always delivered sublingually to protect the molecule from digestive breakdown.
- Capsules: convenient and stable for daily NMN use, though absorption depends on formulation quality.
- Powder: allows flexible dosing and easier titration towards trial-aligned amounts.
- Sublingual: favoured in NADH trials for stability, since the molecule degrades easily in the gut.
Before assuming any product matches trial results, check that the labelled dose sits inside the range that was actually tested.
Safety signals, common side effects and when to seek medical advice
NMN trials testing doses up to 900 milligrams per day in healthy adults reported no safety issues, and the European novel-food dossier for NMN documents absorption data supporting its use as a supplement ingredient at proposed intakes. NADH trials have been short, typically a few weeks, and report general tolerability without flagging long-term safety data.
Mild effects are occasionally noted with NAD+ precursors generally, and neither compound has an extensive long-term safety record in humans. If you are pregnant, breastfeeding, taking prescription medicines, or managing a serious illness, speak with a clinician before adding either supplement to your routine.
Author and publisher proof points: Jord and Vivetus
This comparison was written by Jord, drawing on the same evidence-led approach used across our analyses of NAD+ precursors, including our NMN versus NR review. For readers specifically weighing NMN products, our range includes Vivetus® NMN (60 x 250mg capsules), Vivetus® NMN (60 x 500mg capsules), and Vivetus® NMN poeder. All three are assembled in the Netherlands and ship free on orders over €50.
How to choose between NADH and NMN
The evidence points to a straightforward rule: match the supplement to the goal, check that the dose sits inside the range actually tested in trials, and favour products with transparent labelling over vague marketing claims. For anything beyond general wellness, including existing health conditions or medication use, a conversation with a clinician remains the safer starting point than guesswork.
— Jord
Finding the right NMN product for your routine
Choosing between capsule strengths or powder often comes down to how precisely you want to control your dose and how the trial data lines up with your routine. Our 250mg capsules suit a steady daily dose close to the lower end of trial ranges, our 500mg capsules suit readers targeting the higher doses linked to larger blood NAD increases, and our NMN poeder gives flexibility for adjusting your dose gradually.
Every batch is produced with transparent labelling, so you can check the exact dose against the ranges used in the trials covered above. Browse the full Vivetus® NMN range to compare specifications, or reach out to our customer service team with any product questions before you order.
This article is general information, not a substitute for advice from a qualified doctor. Consult a qualified healthcare professional about your own circumstances before acting on anything here.
FAQ
Is NADH better than NMN for energy?
NADH tends to act faster for short-term energy and endurance, since it participates directly in mitochondrial ATP production, while NMN trials show benefits that build over weeks as blood NAD levels rise. Which is “better” depends on whether you want an immediate boost or sustained support for your NAD+ pool.
What works better than NMN for raising NAD+?
Few supplements have the same volume of dose-dependent human trial data as NMN, though NR (nicotinamide riboside) works through a related pathway and is sometimes compared directly to it. Reviews of NAD+ metabolism note that direct head-to-head human comparisons between precursors remain scarce.
Is it better to take NAD or NADH directly?
NAD+ and NADH supplements are far less studied in humans than their precursors, partly due to stability challenges during digestion. A small sublingual NADH trial reported endurance improvements, but evidence for taking NAD+ itself remains limited compared with precursor-based approaches like NMN.
Who should check with a doctor before taking NADH?
Anyone who is pregnant, breastfeeding, taking prescription medicines, or managing a serious illness should speak with a clinician before starting NADH, since long-term safety data remains limited. This caution applies equally to NMN and other NAD+ precursors given the same gap in long-term human data.